For further details see:
INVO BioScience GAAP EPS of -$0.63 beats by $0.24, revenue of $4.16M beats by $2.84MFor further details see:
INVO BioScience GAAP EPS of -$0.63 beats by $0.24, revenue of $4.16M beats by $2.84MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and with the intrava...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...
2024-04-18 06:37:00 ET Here’s the Top 3 Reasons to Trade Penny Stocks in 2024 Penny stocks represent a unique investment opportunity for those looking to diversify their portfolios with high-growth potential securities. Characterized by their low price per share, typically under ...